Skip to main content
Log in

Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina

  • ORIGINAL ARTICLE
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose

To assess the effects of short-acting nitrates on exercise stress test (EST) results and the relation between EST results and coronary blood flow (CBF) response to nitrates in patients with microvascular angina (MVA).

Methods

We completed 2 symptom/sign limited ESTs on 2 separate days, in a random sequence and in pharmacological washout, in 29 MVA patients and in 24 patients with obstructive coronary artery disease (CAD): one EST was performed without any intervention (control EST, C-EST), and the other after sublingual isosorbide dinitrate, 5 mg (nitrate EST, N-EST). CBF response to nitroglycerin (25 μg) was assessed in the left anterior descending coronary artery by transthoracic Doppler-echocardiography.

Results

At C-EST. ST-segment depression ≥1 mm (STD) was induced in 26 (90 %) and 23 (96 %) MVA and CAD patients, respectively (p = 0.42), whereas at N-EST, STD was induced in 25 (86 %) and 14 (56 %) MVA and CAD patients, respectively (p = 0.01). Time and rate pressure product at 1 mm STD increased during N-EST, compared to C-EST, in CAD patients (475 ± 115 vs. 365 ± 146 s, p < 0.001; and 23511 ± 4352 vs. 20583 ± 6234 bpm⋅mmHg, respectively, p = 0.01), but not in MVA patients (308 ± 160 vs. 284 ± 136 s; p = 0.19; and 21290 ± 5438 vs. 20818 ± 4286 bpm⋅mmHg, respectively, p = 0.35). In MVA patients, a significant correlation was found between heart rate at STD during N-EST and CBF response to nitroglycerin (r = 0.40, p = 0.04).

Conclusions

Short-acting nitrates improve EST results in CAD, but not in MVA patients. In MVA patients a lower nitrate-dependent coronary microvascular dilation may contribute to the lack of effects of nitrates on EST results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–84.

    Article  PubMed  CAS  Google Scholar 

  2. Erbel R, Ge J, Bockisch A, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880–9.

    Article  PubMed  CAS  Google Scholar 

  3. Cannon RO, Epstein SE. “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–43.

    Article  PubMed  Google Scholar 

  4. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart. 2007;93:159–66.

    Article  PubMed  CAS  Google Scholar 

  5. Wessel TR, Arant CB, McGorray SP, et al. NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30:69–74.

    Article  PubMed  Google Scholar 

  6. Radice M, Giudici V, Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am J Cardiol. 1995;75:620–1.

    Article  PubMed  CAS  Google Scholar 

  7. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.

    Article  PubMed  Google Scholar 

  8. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J 2012. [Epub ahead of print]

  9. Neill WA, Judkins MP, Dhindsa DS, Metcalfe J, Kassebaum G, Kloster FE. Clinically suspect ischemic heart disease not corroborated by demonstrable coronary artery disease. Physiologic investigations and clinical course. Am J Cardiol. 1972;29:171–9.

    Article  PubMed  CAS  Google Scholar 

  10. Gavrielides S, Kaski JC, Galassi AR, et al. Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X. Am Heart J. 1991;122:1593–8.

    Article  PubMed  CAS  Google Scholar 

  11. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications. Circulation. 1994;90:2695–700.

    Article  PubMed  CAS  Google Scholar 

  12. Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J. 1994;127:531–5.

    Article  PubMed  CAS  Google Scholar 

  13. Kaski JC. Valenzuela Garcia LF, Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J. 2001;22:283–93.

    Article  PubMed  CAS  Google Scholar 

  14. Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol. 2007;99:1378–83.

    Article  PubMed  Google Scholar 

  15. Voci P, Pizzuto F, Mariano E, Puddu PE, Sardella G, Romeo F. Usefulness of coronary flow reserve measured by transthoracic coronary Doppler ultrasound to detect severe left anterior descending coronary artery stenosis. Am J Cardiol. 2003;92:1320–4.

    Article  PubMed  Google Scholar 

  16. Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography. Comparison with invasive technique. J Am Coll Cardiol. 1998;32:1251–9.

    Article  PubMed  CAS  Google Scholar 

  17. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461–7.

    Article  PubMed  CAS  Google Scholar 

  18. Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res. 1991;68:847–55.

    Article  PubMed  CAS  Google Scholar 

  19. Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation. 1999;100:129–34.

    Article  PubMed  CAS  Google Scholar 

  20. Rajendran S, Chirkov YY. Platelet hyperaggregability: impaired responsiveness to nitric oxide (“platelet NO resistance”) as a therapeutic target. Cardiovasc Drugs Ther. 2008;22:193–203.

    Article  PubMed  CAS  Google Scholar 

  21. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.

    Article  PubMed  Google Scholar 

  22. Bugiardini R, Borghi A, Pozzati A, Ottani F, Morgagni GL, Puddu P. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol. 1993;72:343–7.

    Article  PubMed  CAS  Google Scholar 

  23. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gaetano A. Lanza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russo, G., Di Franco, A., Lamendola, P. et al. Lack of Effect of Nitrates on Exercise Stress Test Results in Patients with Microvascular Angina. Cardiovasc Drugs Ther 27, 229–234 (2013). https://doi.org/10.1007/s10557-013-6439-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-013-6439-z

Keywords

Navigation